SCHEMBL30015474

SCHEMBL30015474

O=C(Nc1ccc(C(=O)O)c(Cl)c1)c1ccc2c(c1)N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)CCC2

nearest known ligand 0.77

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CPT1A P50416 13/20 0.77
▸ CPT1B Q92523 13/20 0.77
▸ CPT2 P23786 12/20 0.77
▸ RORC P51449 5/20 0.59
▸ NR1I2 O75469 1/20 0.56
▸ RORA P35398 1/20 0.56
▸ NR1H2 P55055 1/20 0.56
▸ NR1H3 Q13133 1/20 0.56
▸ RORB Q92753 1/20 0.56
▸ NR1H4 Q96RI1 1/20 0.56
▸ LMNA P02545 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ KMT2A Q03164 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3574235 1.00 CPT1A (0.77) CPT1ACPT1BCPT2RORCNR1I2
SCHEMBL30015215 0.95 CPT1A (0.85) CPT1ACPT1BCPT2RORCLMNA
SCHEMBL3571679 0.95 CPT1A (0.85) CPT1ACPT1BCPT2RORCLMNA
SCHEMBL30015584 0.92 CPT1A (0.90) CPT1ACPT1BCPT2RORCNR1I2
SCHEMBL3575974 0.92 CPT1A (0.90) CPT1ACPT1BCPT2RORCNR1I2
SCHEMBL3573999 0.91 CPT1A (0.66) CPT1ACPT1BCPT2RORCNR1I2
SCHEMBL3582331 0.90 CPT1A (0.90) CPT1ACPT1BCPT2RORCNR1I2
SCHEMBL30015360 0.90 CPT1A (0.90) CPT1ACPT1BCPT2RORCNR1I2
SCHEMBL3572927 0.90 CPT1A (0.76) CPT1ACPT1BCPT2MAPT
SCHEMBL30015618 0.90 CPT1A (0.76) CPT1ACPT1BCPT2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022212568-A9 COMPOUNDS AND COMPOSITIONS FOR MODULATING LIPID METABOLISM 1BASE PHARMACEUTICALS, LLC (US) 2023-11-16 — — WO disclosed
WO-2022212568-A1 COMPOUNDS AND COMPOSITIONS FOR MODULATING LIPID METABOLISM 1BASE PHARMACEUTICALS, LLC (US) 2022-10-06 — — WO disclosed
Send feedback